Similar to breast cancer, aberrantly expressed aromatase in endometriotic stromal cells is stimulated by one of the best-known mediators of inflammation and pain, prostaglandin E2 (PGE2), via the promoter II region of the aromatase gene, resulting in local production of estrogen. The gene discussed is CYP19A1; the disease is breast cancer.